See You in Chicago 2019`
The 2019 National Patient Education Conference will be July 19-21 in Chicago! Will you join us?

Click here to learn more >>

Stepping Out to Cure Scleroderma
Take a Step for Scleroderma

Find a "Stepping Out to Cure Scleroderma" walk/run near you today!

Click here to get started >>

Who We Are

The Scleroderma Foundation is a federally qualified 501(c)(3) nonprofit dedicated to serving the needs of the scleroderma community.  Our primary goal is to raise funds and awareness for our three-fold mission of support, education and research.  All donations are qualified charitable donations to the fullest extent of the law.  Our federal tax identification number is 52-1375827.  All donations are gratefully accepted. 

What is Scleroderma?

Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. The word “scleroderma” comes from two Greek words: “sclero” meaning hard, and “derma” meaning skin. Hardening of the skin is one of the most visible manifestations of the disease.


Download Our Free Scleroderma Information Packet

Can’t download It? Have us mail you a copy!



Visit the eLetter Archive to read the stories behind these headlines.  Submit your email address to receive the eLetter every week.

eLetter #779; September 14, 2018
  • Conference Videos:  "Esclerodermia: Conceptos fundamentales para entender la enfermedad"
  • Outstanding National Advocates:  Dee Burlile and Shelley Van Pelt
  • Emergency Preparedness & Water Damage Recovery Issues
  • Research & Treatment Centers: Mayo Clinic Rheumatology
  • Submit a Video Sharing Your Perspectives on Rare Disease Advocacy (NORD)
  • Kids Get Scleroderma Too: October 26 & 27, Aurora, Colorado
  • WEBINAR:  "What in the World is New with Scleroderma?" October 18, 2018; 7 - 9 p.m. ET
  • "Newly Diagnosed, Need Support"
  • Stepping Out Walks in September
  • Scleroderma Research Grant Deadline is September 17
    • Scleroderma Lung Study III
    • F.D.A. Grants Fast Track Designation to FCX-013


E-Newsletter Signup

Get the latest news.

Please leave this field empty

Our Sponsors